Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.
Press releases published on June 3, 2025

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …

WinnerMining launches new energy power project.
Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of the times and the advancement of technology, people's attitudes towards energy have also changed. People also understand how cloud mining works. However, traditional cloud mining …

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program
Recently disclosed clinical cohort data from high (1x1015 total vg) and low dose (5.7x1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting …

Double Celebration: Urban Windows and Doors Celebrates Two Decades in Business and the 2025 ThreeBestRated® Award
SUDBURY, ONTARIO, CANADA, June 3, 2025 /EINPresswire.com/ -- As the ThreeBestRated® has released their annual updates, the Urban Windows and Doors has once again proved their excellence and proudly upholds their reputation as an industry leader. A …

Cable TV Pioneers Welcome New Class of 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- The Cable TV Pioneers will induct 33 new members in its Class of 2025 at its 59th Annual Banquet in Washington, D.C., Sunday, September 28, 2025. This year’s class includes a variety of leaders and achievers from …

Aecon announces voting results of Annual General Meeting
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Corporation”) announced today that the nominees listed in the Management Information Circular dated May 5, 2025, were elected as directors of Aecon, to hold office …

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today …

Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees. Effective June 1, 2025, in connection with commencing employment, two …

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …

Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee …

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Beyond Oil Issues Clarification Regarding Previous German-Language Media Activities
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission (the “BCSC”), Beyond Oil Ltd. (CSE: BOIL; OTCQB: BEOLF; Frankfurt: UH9) (“Beyond Oil” or the “Company”) today …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

CBL International Limited Announces Share Repurchase Program Repurchase Reflects the Board’s Confidence in Long-Term Growth
Kuala Lumpur, Malaysia, June 03, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ: BANL) (the “Company” or “CBL”), the listing vehicle of Banle Group (“Banle” or “the Group”), today announced that its Board of Directors has authorized a share …

HeartCore Signs 15th Go IPO Contract
NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement (“ …

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …